Compare CDXS & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDXS | XFLT |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 265.3M |
| IPO Year | 2008 | N/A |
| Metric | CDXS | XFLT |
|---|---|---|
| Price | $1.49 | $17.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 796.1K | 89.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.17% |
| EPS Growth | ★ 43.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $3.02 |
| 52 Week High | $3.87 | $19.48 |
| Indicator | CDXS | XFLT |
|---|---|---|
| Relative Strength Index (RSI) | 23.79 | 47.60 |
| Support Level | $1.10 | $17.03 |
| Resistance Level | $1.86 | $19.48 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 5.33 | 52.62 |
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.